Cart
sales@molnova.com
Buformin hydrochloride
CAS No. 1190-53-0
Buformin hydrochloride ( NSC 528218; NSC-528218; NSC528218 )
Catalog No. M23359 CAS No. 1190-53-0
Buformin hydrochloride is a potent AMPK activator,an oral antidiabetic drug of the biguanide class.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 58 | In Stock |
|
| 100MG | 87 | In Stock |
|
| 200MG | 142 | In Stock |
|
| 500MG | 267 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBuformin hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionBuformin hydrochloride is a potent AMPK activator,an oral antidiabetic drug of the biguanide class.
-
DescriptionBuformin hydrochloride is a potent AMPK activator,an oral antidiabetic drug of the biguanide class. Buformin delays the absorption of glucose from the gastrointestinal tract increases insulin sensitivity and glucose uptake into cells and inhibits synthesis of glucose by the liver. Biguanides may antagonize the action of glucagon, thus reducing fasting glucose levels.
-
SynonymsNSC 528218; NSC-528218; NSC528218
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorAMPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1190-53-0
-
Formula Weight193.7
-
Molecular FormulaC6H16ClN5
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESCCCCN=C(N)N=C(N)N.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Amanda B Parris, et al. Buformin hydrochloride Inhibits the Stemness of erbB-2-overexpressing Breast Cancer Cells and Premalignant Mammary Tissues of MMTV-erbB-2 Transgenic Mice. J Exp Clin Cancer Res
molnova catalog
related products
-
AMAROGENTIN
Amarogentin is mainly extracted from Swertia and Gentiana roots. It plays cemopreventive/therapeutic role during liver carcinogenesis through modulation of cell cycle and apoptosis
-
Onjisaponin B
Onjisaponin B induces autophagy via the AMPK-mTOR signaling pathway, increases the NGF level and accelerates both the removal of mutant huntingtin and A53T α±-synuclein, it may have potential therapeutic effects on Parkinson disease, Alzheimer disease and Huntington disease.
-
MT 63-78
MT 63-78 is a specific and effective direct AMPK activator (EC50: 25 μM). MT 63-78 blocks prostate cancer growth by inhibiting the lipogenesis and mTORC1 pathways.
